LFCR — LIFECORE BIOMEDICAL INC

Ownership history in Tactive Advisors, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Tactive Advisors, LLC reported a position in LIFECORE BIOMEDICAL INC (LFCR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q2)
Avg. % of fund
0.04%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 16,402 +907 +5.9% 0.03% $121K $7.36
2025 Q2 INITIATED 15,495 — — 0.04% $126K $8.12
% of Fund (quarterly)    LFCR price (monthly, adj. close)

Other funds also holding LFCR

As of 2025 Q4 — sorted by position size

WYNNEFIELD CAPITAL INC 3Y 7Y 21.63% Legion Partners Asset Management, LLC 3Y 7Y 21.25% 22NW, LP 3Y 7Y 9.69% 325 CAPITAL LLC 3Y 6.2% Greenhaven Road Investment Management, L.P. 3Y 5.07% GRIZZLYROCK CAPITAL, LLC 4.55% DCF Advisers, LLC 3Y 0.97% DBA TRADING, LLC 0.39% Diametric Capital, LP 3Y 7Y 0.26% Quinn Opportunity Partners LLC 3Y 7Y 0.08%
← Back to Tactive Advisors, LLC Holdings